1. National Health Surveillance Agency of Brazil (ANVISA). Resolution RDC no 31. Provides information about the studies of pharmaceutical equivalence and comparative dissolution profile. 2010.
2. The Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA). Determination and comparison of dissolution curves of ordinary solid preparations guideline. 2016.
3. European Medicines Agency (EMA). Committee for Medicinal Products for Human Use (CHMP). Guideline on the Investigation of Bioequivalence. Doc.Ref.: CPMP/EWP/QWP/1401/98. Rev. 1/Corr, London. 2010.
4. U.S. Department of Health and Human Services - Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry: Immediate release solid oral dosage forms: Scale-up and postapproval changes: chemistry, manufacturing, and controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation. 1995.
5. U.S. Department of Health and Human Services - Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry: Dissolution testing of immediate release solid oral dosage forms. 1997.